Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,007 CHF | +0.70% | +3.33% | +15.01% |
Apr. 18 | UBS Raises Givaudan to Neutral from Sell, Raises PT | MT |
Apr. 18 | GIVAUDAN : UBS raises its recommendation | CF |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The group's high margin levels account for strong profits.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- The group shows a rather high level of debt in proportion to its EBITDA.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 37.49 times its estimated earnings per share for the ongoing year.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+15.01% | 40.32B | B+ | ||
+11.31% | 62.8B | A- | ||
-5.19% | 45.4B | A- | ||
+18.19% | 25.83B | A- | ||
+5.07% | 18.21B | C+ | ||
+0.04% | 17.41B | B+ | ||
+4.48% | 15.64B | B+ | ||
-17.27% | 15.51B | A- | ||
-20.22% | 13.42B | C+ | ||
-28.15% | 12.79B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- GIVN Stock
- Ratings Givaudan SA